Idhifa is a prescription medication used to treat a specific type of acute myeloid leukemia (AML) in adults who have a certain genetic mutation known as isocitrate dehydrogenase-2 (IDH2). This mutation causes the body to produce abnormal proteins that can lead to the development of AML.

Idhifa works by targeting and inhibiting the mutated IDH2 enzyme, which helps to slow down the growth and spread of cancer cells. By blocking this enzyme, Idhifa can help to reduce the number of abnormal cells in the bone marrow and blood, ultimately improving the symptoms and outcomes for patients with this type of AML.

It is important to follow your healthcare provider’s instructions carefully when taking Idhifa. This medication is typically taken orally once daily with or without food. Your doctor will determine the appropriate dosage based on your individual medical history and response to treatment.

As with any medication, Idhifa may cause side effects. Common side effects may include nausea, vomiting, diarrhea, fatigue, and decreased appetite. It is important to report any side effects to your healthcare provider so they can be properly managed.

It is also important to inform your doctor of any other medications or supplements you are taking, as they may interact with Idhifa. Your healthcare provider will monitor your progress and adjust your treatment plan as needed to ensure the best possible outcomes.

Overall, Idhifa is an important treatment option for adults with IDH2-mutated AML. By working with your healthcare team and following their guidance, you can help to manage your condition and improve your quality of life.